Cystic Fibrosis Remote Monitoring System to Support Resource-Limited Communities
囊性纤维化远程监测系统支持资源有限的社区
基本信息
- 批准号:9439668
- 负责人:
- 金额:$ 59.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-04-02 至 2019-06-30
- 项目状态:已结题
- 来源:
- 关键词:AccreditationAcuteAdherenceAdultAdvocateAffectAppointments and SchedulesBacterial InfectionsBiomedical TechnologyBronchiBronchiolesCaringCase ManagementCellular PhoneChestChildChronicChronic DiseaseClimateClinic VisitsClinical ManagementClinics and HospitalsCommunicationCommunitiesCystic FibrosisDataDevicesDiagnosticDiseaseEarly DiagnosisEcosystemEducationEvaluationFeedbackFocus GroupsFoundationsFrequenciesGeographyGlandGoalsHealth care facilityHealthcare SystemsHigh-Frequency Chest Wall CompressionHome environmentHospitalizationHospitalsInfectionInflammationInheritedInternetLungMedical Care CostsMedical DeviceMethodsMinnesotaMonitorMontanaMucous body substanceOutpatientsPatient CarePatientsPerformancePhasePilot ProjectsPopulationProcessProviderPulmonary function testsQuality of lifeRecurrenceRegimenResourcesRespiratory FailureRespiratory physiologyRuralRural CommunitySecureServicesSeveritiesSouth DakotaSpirometrySweatSymptomsSystemTechniquesTestingThickTransportationTravelUnited StatesUniversitiesVirus DiseasesWeatherWireless TechnologyWorkWyomingbasecloud basedcostcystic fibrosis patientsdesigngastrointestinal systemhealth care serviceinnovationinsightiterative designmedical specialtiesmonitoring deviceprogramspulmonary functionrepositoryrespiratoryrural areastandard of caretherapy adherencetooltrendusabilityverification and validationweb app
项目摘要
Abstract
Twenty percent of the U.S. population resides in rural communities. In rural areas, residents need to travel
greater distances to access specialty services of the healthcare system. Typically, healthcare facilities in these
rural areas are small and provide limited services. Often, due to geographic distance, extreme weather
conditions, environmental and climatic barriers, lack of public transportation, and challenging roads, rural
residents may be limited or prohibited from accessing specialty health care services. In this phase II proposal,
Koronis Biomedical Technologies (KBT) proposes a system to overcome some of these barriers by monitoring
cystic fibrosis (CF) patients at home. Currently, the standard of care for reoccurring CF respiratory
exacerbations includes coming to a specialized CF clinic or the hospital for pulmonary function evaluation
when symptoms occur. Pulmonary function tests help clinicians know when lung function has declined.
However, clinicians currently do not monitor lung function at home, nor do clinicians have any insight on
therapy adherence. There are currently 120 CF centers in the U.S. accredited by the Cystic Fibrosis
Foundation with only five in the entire states of Minnesota (2), North/South Dakota (2), Montana (1) and
Wyoming (0). In many cases, patients travel a long distance to reach these specialized CF centers. The
proposed system creates an innovative home system that connects patients in rural areas with clinicians and
provides a feedback loop between therapy and diagnostic monitoring. The phase II proposal will develop a web
application that will allow secure remote access to pulmonary function data and therapy adherence. This
system will provide a means of early detection of pulmonary exacerbation and reducing the number of costly
and stressful hospitalizations and clinic visits.
抽象的
百分之二十的美国人口居住在农村社区。在农村地区,居民需要出行
获得医疗保健系统专业服务的距离更远。通常,这些地区的医疗机构
农村地区面积较小,提供的服务有限。通常,由于地理距离、极端天气
农村地区的条件、环境和气候障碍、缺乏公共交通以及具有挑战性的道路
居民可能被限制或禁止获得专业医疗保健服务。在这个第二阶段提案中,
Koronis Biomedical Technologies (KBT) 提出了一种系统,通过监控来克服其中一些障碍
家中的囊性纤维化(CF)患者。目前,复发性 CF 呼吸系统疾病的护理标准
病情加重包括前往专门的 CF 诊所或医院进行肺功能评估
当症状出现时。肺功能测试可以帮助临床医生了解肺功能何时下降。
然而,临床医生目前并不在家中监测肺功能,也没有任何见解
治疗依从性。目前美国有 120 个获得囊性纤维化协会认可的囊性纤维化中心
基金会在明尼苏达州 (2)、北/南达科他州 (2)、蒙大拿州 (1) 和
怀俄明州 (0)。在许多情况下,患者需要长途跋涉才能到达这些专门的囊性纤维化中心。这
拟议的系统创建了一个创新的家庭系统,将农村地区的患者与临床医生联系起来,
在治疗和诊断监测之间提供反馈回路。第二阶段提案将开发一个网络
应用程序将允许安全地远程访问肺功能数据和治疗依从性。这
该系统将提供一种早期发现肺部病情恶化并减少昂贵的治疗次数的方法
以及紧张的住院和就诊。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Patrick Lichter其他文献
Patrick Lichter的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Patrick Lichter', 18)}}的其他基金
Interactive Training Tool Providing Technique Feedback for COPD Medication Delivery
交互式培训工具为慢性阻塞性肺病药物输送提供技术反馈
- 批准号:
10579858 - 财政年份:2021
- 资助金额:
$ 59.68万 - 项目类别:
Interactive Training Tool Providing Technique Feedback for COPD Medication Delivery
交互式培训工具为慢性阻塞性肺病药物输送提供技术反馈
- 批准号:
10358639 - 财政年份:2021
- 资助金额:
$ 59.68万 - 项目类别:
Interactive Training Tool Providing Technique Feedback for COPD Medication Delivery
交互式培训工具为慢性阻塞性肺病药物输送提供技术反馈
- 批准号:
10154940 - 财政年份:2021
- 资助金额:
$ 59.68万 - 项目类别:
Portable Low-Cost Pulmonary Forced Oscillation Technique Instrument Using a Novel Sensor Design
采用新型传感器设计的便携式低成本肺强迫振荡技术仪器
- 批准号:
9347312 - 财政年份:2017
- 资助金额:
$ 59.68万 - 项目类别:
Cystic Fibrosis Remote monitoring System to Support Resource-Limited Communities
囊性纤维化远程监测系统支持资源有限的社区
- 批准号:
8853002 - 财政年份:2015
- 资助金额:
$ 59.68万 - 项目类别:
Inhaler Training Device for Asthma and COPD Patient Education
用于哮喘和慢性阻塞性肺病患者教育的吸入器训练装置
- 批准号:
8713788 - 财政年份:2014
- 资助金额:
$ 59.68万 - 项目类别:
UltraSonic Spirometer for Home Monitoring of Asthma Patients
用于家庭监测哮喘患者的超声波肺活量计
- 批准号:
8251860 - 财政年份:2012
- 资助金额:
$ 59.68万 - 项目类别:
A Low Power Wireless Pulse Oximeter Sensor for Unobtrusive Wearable Applications
适用于低调可穿戴应用的低功耗无线脉搏血氧计传感器
- 批准号:
8911749 - 财政年份:2011
- 资助金额:
$ 59.68万 - 项目类别:
A Low Power Wireless Pulse Oximeter Sensor for Unobtrusive Wearable Applications
适用于低调可穿戴应用的低功耗无线脉搏血氧计传感器
- 批准号:
8645020 - 财政年份:2011
- 资助金额:
$ 59.68万 - 项目类别:
相似国自然基金
Tenascin-X对急性肾损伤血管内皮细胞的保护作用及机制研究
- 批准号:82300764
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
活性脂质Arlm-1介导的自噬流阻滞在儿童T细胞急性淋巴细胞白血病化疗耐药逆转中的作用机制研究
- 批准号:82300182
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
PHF6突变通过相分离调控YTHDC2-m6A-SREBP2信号轴促进急性T淋巴细胞白血病发生发展的机制研究
- 批准号:82370165
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
KIF5B调控隧道纳米管介导的线粒体转运对FLT3-ITD阳性急性髓系白血病的作用机制
- 批准号:82370175
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Changes in Provider Practices for the Management of Cystic Fibrosis (CF) in the Era of Highly Effective Modulator Therapy
高效调节剂治疗时代囊性纤维化 (CF) 治疗提供者实践的变化
- 批准号:
10543981 - 财政年份:2021
- 资助金额:
$ 59.68万 - 项目类别:
Oral v Injection Naltrexone in Hospital: Comparative Effectiveness for Alcoholism
医院口服纳曲酮与注射纳曲酮:治疗酒精中毒的效果比较
- 批准号:
8932640 - 财政年份:2014
- 资助金额:
$ 59.68万 - 项目类别:
Oral v Injection Naltrexone in Hospital: Comparative Effectiveness for Alcoholism
医院口服纳曲酮与注射纳曲酮:治疗酒精中毒的效果比较
- 批准号:
8693153 - 财政年份:2014
- 资助金额:
$ 59.68万 - 项目类别:
Oral v Injection Naltrexone in Hospital: Comparative Effectiveness for Alcoholism
医院口服纳曲酮与注射纳曲酮:治疗酒精中毒的效果比较
- 批准号:
9539171 - 财政年份:2014
- 资助金额:
$ 59.68万 - 项目类别: